Skip to content

Lifeflight: Fentanyl Versus Morphine

Efficacy and Adverse Events of Morphine and Fentanyl in an Aeromedical Setting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00580489
Enrollment
204
Registered
2007-12-24
Start date
2006-08-31
Completion date
2008-12-31
Last updated
2022-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Events, Pain Relief

Keywords

helicopter, aeromedical, pain relief, analgesia, fentanyl, morphine, adverse events

Brief summary

The study is exempt from informed consent by the MetroHealth Medical Center institutional review board (IRB), because two standards of care are used and there is no increased clinical risk to the patient due to the study. The researchers randomize either fentanyl or morphine to be given to trauma patients and record how their pain scale is treated along with observing for adverse events. They are looking to see if the hypothesized benefits of fentanyl (which is much more expensive than morphine) actually exist.

Detailed description

Periodic reports are made to the IRB.

Interventions

DRUGeither fentanyl or morphine

either morphine 4mg IV or fentanyl 50mcg IV

Sponsors

MetroHealth Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* Trauma patient * Able to speak/communicate a pain scale

Exclusion criteria

* Age \<18 * Age \>69 * Initially or any time hypotensive * Prisoner

Design outcomes

Primary

MeasureTime frameDescription
Mean Change in Numeric Pain Score (NPS) From First to Last DoseMedication was administered over a mean transport time of 37 minutes in the Morphine group and 43 minutes in the Fentanyl group.Mean difference in the numeric pain score (NPS) from the first dose to the final dose of medication administered. A significant mean pain score change is defined as greater than or equal to 2 Numeric Pain Score (NPS) 0-10, 0 Least pain, 10 most pain

Secondary

MeasureTime frameDescription
Recording of Instance of Narcotic Side Effects.Groups were observed a mean of 37 minutes in the Morphine Group and a mean of 43 minutes in the Fentanyl group for side effects.Instances of narcotic side effects (vital sign derangement, itching, nausea/vomiting) .

Countries

United States

Participant flow

Participants by arm

ArmCount
Morphine
morphine for trauma patients transported by helicopter either fentanyl or morphine: either morphine 4mg IV or fentanyl 50mcg IV
103
Fentanyl
fentanyl for trauma patients transported by helicopter either fentanyl or morphine: either morphine 4mg IV or fentanyl 50mcg IV
97
Total200

Baseline characteristics

CharacteristicMorphineFentanylTotal
Age, Continuous38 years
STANDARD_DEVIATION 13
39 years
STANDARD_DEVIATION 13
38.5 years
STANDARD_DEVIATION 13
Initial Numeric Pain Score8.0 units on a scale
STANDARD_DEVIATION 2
8.0 units on a scale
STANDARD_DEVIATION 1.8
8.0 units on a scale
STANDARD_DEVIATION 1.9
Sex: Female, Male
Female
26 Participants23 Participants49 Participants
Sex: Female, Male
Male
77 Participants74 Participants151 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1030 / 97
serious
Total, serious adverse events
0 / 1030 / 97

Outcome results

Primary

Mean Change in Numeric Pain Score (NPS) From First to Last Dose

Mean difference in the numeric pain score (NPS) from the first dose to the final dose of medication administered. A significant mean pain score change is defined as greater than or equal to 2 Numeric Pain Score (NPS) 0-10, 0 Least pain, 10 most pain

Time frame: Medication was administered over a mean transport time of 37 minutes in the Morphine group and 43 minutes in the Fentanyl group.

Population: 4 subjects were excluded from analysis, 1 from the Morphine Group and 3 from the Fentanyl group to achieve the baseline participants for data analysis 103 morphine and 97 fentanyl.

ArmMeasureValue (MEAN)Dispersion
MorphineMean Change in Numeric Pain Score (NPS) From First to Last Dose2.2 score on a scaleStandard Deviation 2
FentanylMean Change in Numeric Pain Score (NPS) From First to Last Dose2.5 score on a scaleStandard Deviation 2.7
Secondary

Recording of Instance of Narcotic Side Effects.

Instances of narcotic side effects (vital sign derangement, itching, nausea/vomiting) .

Time frame: Groups were observed a mean of 37 minutes in the Morphine Group and a mean of 43 minutes in the Fentanyl group for side effects.

Population: 4 subjects were excluded from analysis, 1 from the Morphine Group and 3 from the Fentanyl group to achieve the baseline participants for data analysis 103 morphine and 97 fentanyl.

ArmMeasureValue (NUMBER)
MorphineRecording of Instance of Narcotic Side Effects.0 participants
FentanylRecording of Instance of Narcotic Side Effects.0 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026